For decades, Sialkot has been the backbone of a global surgical instruments supply chain. When a surgeon in Germany or France picks up a pair of forceps or a retractor, chances are high it was forged, ground, and polished in our city.
But the regulatory landscape in Europe has changed fundamentally. The EU Medical Device Regulation (MDR) 2017/745 is no longer a future deadline — it is fully applicable. And for Pakistani manufacturers, this is not just a paperwork exercise. It is a fundamental shift in how we must prove quality, traceability, and safety.
MDR is not going away. For Sialkot to maintain its global leadership, we must move from being “low-cost” suppliers to being “documented and traceable” partners.
What has changed under MDR?
Under the old MDD (Medical Devices Directive), a Sialkot manufacturer of non-sterile, Class I instruments (like basic scalpels or scissors) could largely self-certify. The responsibility sat mainly with the European importer. Under MDR, that is gone. Even for Class I instruments, the scrutiny has increased. You now need:
- More detailed technical documentation — not just a catalogue, but full design and manufacturing process files.
- A robust Quality Management System (QMS) — typically certified to ISO 13485:2016, which is now the baseline.
- Clinical evaluation reports — even for basic instruments, you must show evidence of safety and performance.
- Post-market surveillance (PMS) — a proactive plan to monitor how your instruments perform once they are in the field.
For instruments that are sterile or have a measuring function, the requirements are even higher, involving Notified Body approval.
What Sialkot suppliers must demonstrate today
If you are exporting to the EU, your buyers will likely ask for three clear things.
ISO 13485 Certification
The old ISO 9001 is no longer sufficient for most serious buyers. You need a quality system that specifically covers medical devices — certified by an accredited body.
A Clear Economic Operator in the EU
MDR requires a legal entity within the EU (an Authorised Representative or importer) who takes legal responsibility for the device. As a Sialkot supplier, you cannot simply ship and walk away. You must have a formal EC-REP agreement.
Traceability via UDI
Each device or batch must carry a Unique Device Identification code. Your labelling and packaging processes must be able to generate, apply, and record UDI barcodes — for many smaller workshops, this requires new investment.
What European buyers should be asking for
To colleagues in Europe who are sourcing from Sialkot: do not assume your long-term supplier understands MDR fully. Ask specific questions:
- Request their ISO 13485 certificate and verify its scope against what they are supplying you.
- Ask for a copy of their technical file for a sample instrument.
- Request their post-market surveillance report — even a basic one.
- Confirm who their EU Authorised Representative is, and get the contract details.
If your Sialkot supplier cannot produce these, they are not compliant — and you are carrying the legal risk.
The practical reality for Sialkot
Many manufacturers here feel this is heavy bureaucracy. In some ways, it is. But it also creates a real opportunity. The middle-tier suppliers who treat MDR as a one-time paperwork exercise will struggle. The serious ones who integrate quality and documentation into their daily production will gain trust — and long-term European contracts.
Several leading local manufacturers have already invested in new cleanrooms, digital traceability systems, and dedicated regulatory staff. They are now preferred suppliers for top European distributors. The message is clear: MDR compliance is no longer optional — it is the price of market access.
Key Takeaway
EU MDR 2017/745 has raised the compliance bar for all Sialkot suppliers exporting to Europe. ISO 13485 certification, an EU Authorised Representative, and UDI traceability are now baseline requirements, not optional extras. Suppliers who move now will keep their buyers. Those who delay will lose them.